Literature DB >> 8413615

Residues in the TATA-binding protein required to mediate a transcriptional response to retinoic acid in EC cells.

M Keaveney1, A Berkenstam, M Feigenbutz, G Vriend, H G Stunnenberg.   

Abstract

The eukaryotic TATA-binding protein TBP, which is required for transcription by RNA polymerase II, is tightly associated with a particular set of factors in the TFIID complex, and as such provides a target for transcriptional regulation exerted by upstream factors. An embryonic carcinoma (EC) cell-specific activity like that of the viral factor E1A has been implicated in the mediation of transactivation from the retinoic acid receptor to human TBP, but yeast TBP cannot perform this function. Using TBP mutants with an altered TATA-box-binding specificity, we show here that yeast TBP can mediate transcriptional activation in mammalian cells and that its inability to convey retinoic acid-dependent transactivation in EC cells is due to specific residues in its core region. These residues preclude a functional association with the cellular E1A-like activity. TBP is thus a target for retinoic acid-dependent transactivation in EC cells by providing a surface for interaction with the EC cell-specific E1A-like activity.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8413615     DOI: 10.1038/365562a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  25 in total

1.  Artificial recruitment of TFIID, but not RNA polymerase II holoenzyme, activates transcription in mammalian cells.

Authors:  D R Dorris; K Struhl
Journal:  Mol Cell Biol       Date:  2000-06       Impact factor: 4.272

2.  DA-complex assembly activity required for VP16C transcriptional activation.

Authors:  N Kobayashi; P J Horn; S M Sullivan; S J Triezenberg; T G Boyer; A J Berk
Journal:  Mol Cell Biol       Date:  1998-07       Impact factor: 4.272

3.  A severely defective TATA-binding protein-TFIIB interaction does not preclude transcriptional activation in vivo.

Authors:  M Lee; K Struhl
Journal:  Mol Cell Biol       Date:  1997-03       Impact factor: 4.272

4.  UTF1, a novel transcriptional coactivator expressed in pluripotent embryonic stem cells and extra-embryonic cells.

Authors:  A Okuda; A Fukushima; M Nishimoto; A Orimo; T Yamagishi; Y Nabeshima; M Kuro-o; Y i Nabeshima; K Boon; M Keaveney; H G Stunnenberg; M Muramatsu
Journal:  EMBO J       Date:  1998-04-01       Impact factor: 11.598

5.  Mutations in the carboxy-terminal domain of TBP affect the synthesis of human immunodeficiency virus type 1 full-length and short transcripts similarly.

Authors:  P S Pendergrast; D Morrison; W P Tansey; N Hernandez
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

6.  Synergistic and promoter-selective activation of transcription by recruitment of transcription factors TFIID and TFIIB.

Authors:  E Gonzalez-Couto; N Klages; M Strubin
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-22       Impact factor: 11.205

7.  Direct isolation of human transcribed sequences from yeast artificial chromosomes through the application of RNA fingerprinting.

Authors:  I H Still; P Vince; J K Cowell
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-16       Impact factor: 11.205

8.  Evidence that TAF-TATA box-binding protein interactions are required for activated transcription in mammalian cells.

Authors:  Lisa S Martel; Helen J Brown; Arnold J Berk
Journal:  Mol Cell Biol       Date:  2002-04       Impact factor: 4.272

9.  Transcription activation of polyadenylated nuclear rna by rta in human herpesvirus 8/Kaposi's sarcoma-associated herpesvirus.

Authors:  M J Song; H J Brown; T T Wu; R Sun
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

10.  Retinoid-induced repression of human immunodeficiency virus type 1 core promoter activity inhibits virus replication.

Authors:  J W Maciaszek; S J Coniglio; D A Talmage; G A Viglianti
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.